KF, D., B, H., A, B., RT, C., AD, H., PS, J., . . . JJV, M. (2026). Benefit of early initiation of disease-modifying therapy in community-based patients with suspected heart failure. European heart journal, 47(8), 927. https://doi.org/10.1093/eurheartj/ehaf675
Chicago Style (17th ed.) CitationKF, Docherty, et al. "Benefit of Early Initiation of Disease-modifying Therapy in Community-based Patients with Suspected Heart Failure." European Heart Journal 47, no. 8 (2026): 927. https://doi.org/10.1093/eurheartj/ehaf675.
MLA (9th ed.) CitationKF, Docherty, et al. "Benefit of Early Initiation of Disease-modifying Therapy in Community-based Patients with Suspected Heart Failure." European Heart Journal, vol. 47, no. 8, 2026, p. 927, https://doi.org/10.1093/eurheartj/ehaf675.